Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $32 at Mizuho
Tweet
Share
E-mailGet Alerts AMLX Hot Sheet
Price: $23.35 -1.18%
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Mizuho analyst Graig Suvannavejh raised the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $32.00 (from $27.00) while maintaining a Buy rating.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Macquarie Upgrades Hankook Tire Co Ltd (161390:KS) to Outperform
- Workman Co Ltd (7564:JP) (WKISF) PT Lowered to JPY8,100 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
